Please assess the completion status of the following clinical trial:

Trial Title: Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient who have been informed about the research~* Patients with national health insurance cover~* Patients aged between 18 and 75 years~* Patients with stage 3 kidney failure (30 ml/min \< cl creat \< 59 ml/min) diabetic or not~* Patients with stage 5 kidney failure (cl creat \< 15 ml/mn) diabetic or not and requiring dialysis.~Exclusion Criteria:~* Patients under guardianship~* Pregnant or breast-feeding women~* Infection (including peritonitis in peritoneal dialysis, infection of the catheter insertion site),~* Neoplastic disease,~* Systemic diseases in flare,~* Patients positive for Human Immunodeficience Virus (HIV),~* Patients on immunosuppressants~* Patients taking antioxidants (selenium, vitamin C and/or E)~* Patient on statins

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- group with stage 3 kidney failure (diabetic or not) (Type: OTHER): None
- group with stage 5 kidney failure (diabetic or not) (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).